O.026 Vaccination against hepatitis B in liver transplant recipients with history of hepatitis B infection: analysis of cellular immune response shows evidence of HBsAg specific regulatory T cells

Vaccination against hepatitis B in liver

Vaccination against hepatitis B in liver transplant recipients: Pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells

✍ Tanja Bauer; Matthias Günther; Ulrich Bienzle; Ruth Neuhaus; Wolfgang Jilg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

After liver transplantation for hepatitis-B-related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most at